This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Gentian as. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Berit Løseth: Innovator in Clinical Assays
Introduction
Berit Løseth is a notable inventor based in Oslo, Norway. She has made significant contributions to the field of clinical diagnostics, particularly through her innovative patent related to NT-proBNP quantification.
Latest Patents
Løseth holds a patent for a "Highly sensitive particle enhanced assay for the quantification of NT-proBNP." This invention allows for the determination of NT-proBNP in biological samples using at least one antibody that recognizes an epitope of NT-proBNP in both glycosylated and non-glycosylated forms. The assay employs isolated polyclonal antibodies or mixtures of monoclonal antibodies coated onto particles, achieving a coating ratio of 6-60%. This technology can be utilized in various automated clinical analyzers, enhancing the accuracy and efficiency of NT-proBNP testing.
Career Highlights
Løseth's career is marked by her dedication to advancing clinical diagnostics. Her work at Gentian AS has positioned her as a key player in the development of innovative assays that improve patient care.
Collaborations
Løseth collaborates with talented professionals such as Ingvild Gudim and Torsten Knüttel, contributing to a dynamic research environment that fosters innovation.
Conclusion
Berit Løseth's contributions to the field of clinical diagnostics through her patent on NT-proBNP quantification exemplify her commitment to improving healthcare solutions. Her work continues to influence the landscape of clinical assays and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile